載入...
Relapse recovery: The forgotten variable in multiple sclerosis clinical trials
OBJECTIVE: To determine whether basing the decision to initiate immediate vs delayed disease-modifying therapy (DMT) on extent of recovery after initial relapse affects long-term disability accumulation in a multiple sclerosis (MS) evidence-based setting. METHODS: We analyzed the double-blind, place...
Na minha lista:
| 發表在: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Lippincott Williams & Wilkins
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6943367/ https://ncbi.nlm.nih.gov/pubmed/31848231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000653 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|